Understanding high endothelial venules: Lessons for cancer immunology

OncoImmunology

Volumn 4, Issue 6, 2015, Pages

  Ager, Ann ^a   May, Michael J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dendritic cells; High endothelial venules; Lymphotoxin b receptor; T cell homing; Tumor immunotherapy

Indexed keywords

ADDRESSIN; LYMPHOTOXIN BETA RECEPTOR; LYSOPHOSPHATIDIC ACID; VASCULOTROPIN;

ANGIOGENESIS; BREAST CANCER; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL MIGRATION; CHRONIC INFLAMMATION; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; NONHUMAN; RECEPTOR DOWN REGULATION; REVIEW; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME; VENULE;

EID: 84944463669     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1008791     Document Type: Review

References (142)

1. Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012; 12:762-73; PMID:23018291; http://dx.doi.org/10.1038/nri3298
2. Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol 2013; 13:309-20; PMID:23598650; http:// dx.doi.org/10.1038/nri3442
3. Gowans JL, Knight EJ. The route of recirculation of lymphocytes in the rat. Proc R Soc Series B 1964; 159:257-82; http://dx.doi.org/10.1098/ rspb.1964.0001
4. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006; 25:989-1001; PMID:17112751; http://dx.doi.org/10.1016/j. immuni.2006.10.011
5. Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009; 9:618-29; PMID:19644499; http://dx.doi.org/10.1038/nri2588
6. Turley SJ, Fletcher AL, Elpek KG. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol 2010; 10:813-25; PMID:21088682; http://dx.doi.org/ 10.1038/nri2886
7. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, Cyster JG, Luther SA. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007; 8:1255-65; PMID:17893676; http://dx.doi.org/10.1038/ni1513
8. Gowans JL. The recirculation of lymphocytes from blood to lymph in the rat. J Physiol 1959; 146:54-69; PMID:13655215; http://dx.doi.org/10.1113/ jphysiol.1959.sp006177
9. Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998; 187:205-16; PMID:9432978; http://dx.doi.org/ 10.1084/jem.187.2.205
10. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004; 22:129-56; PMID:15032576; http://dx.doi.org/10.1146/ annurev.immunol.21.090501.080131
11. Anderson AO, Anderson ND. Lymphocyte emigration from high endothelial venules in rat lymph nodes. Immunol 1976; 31:731-48; PMID:992709
12. Anderson ND, Anderson AO, Wyllie RG. Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunol 1976; 31:455-73; PMID:1027726
13. Belisle C, Sainte-Marie G. The narrowing of high endothelial venules of the rat lymph node. Anat Rec 1985; 211:184-91; PMID:3883847; http://dx.doi. org/10.1002/ar.1092110210
14. Fossum S, Smith ME, Ford WL. The migration of lymphocytes across specialized vascular endothelium VII. The migration of T and B lymphocytes from the blood of the athymic, nude rat. Scand J Immunol 1983; 17:539-50; PMID:6603012; http://dx.doi.org/ 10.1111/j.1365-3083.1983.tb00822.x
15. Pfeiffer F, Kumar V, Butz S, Vestweber D, Imhof BA, Stein JV, Engelhardt B. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol 2008; 38:2142-55; PMID:18629939; http://dx.doi.org/ 10.1002/eji.200838140
16. Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988; 107:1853-62; PMID:2460470; http://dx.doi.org/10.1083/ jcb.107.5.1853
17. Uchimura K, Rosen SD. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol 2006; 27:559-65; PMID:17049924; http:// dx.doi.org/10.1016/j.it.2006.10.007
18. Mitoma J, Bao X, Petryanik B, Schaerli P, Gauguet JM, Yu SY, Kawashima H, Saito H, Ohtsubo K, Marth JD et al. Critical functions of N-glycans in Lselectin-mediated lymphocyte homing and recruitment. Nat Immunol 2007; 8:409-18; PMID:17334369; http://dx.doi.org/10.1038/ni1442
19. Hirakawa J, Tsuboi K, Sato K, Kobayashi M, Watanabe S, Takakura A, Imai Y, Ito Y, Fukuda M, Kawashima H. Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N-and O-glycans in lymphocyte homing. J Biol Chem 2010; 285:40864-78; PMID:20929857; http://dx.doi.org/ 10.1074/jbc.M110.167296
20. Arata-Kawai H, Singer MS, Bistrup A, Zante A, Wang YQ, Ito Y, Bao X, Hemmerich S, Fukuda M, Rosen SD. Functional contributions of N-and O-glycans to L-selectin ligands in murine and human lymphoid organs. Am J Pathol 2011; 178:423-33; PMID:21224079; http://dx.doi.org/10.1016/j. ajpath.2010.11.009
21. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 1988; 331:41-6; PMID:3340147; http://dx.doi.org/ 10.1038/366695a0
22. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993; 366:695-8; PMID:7505053; http://dx.doi.org/10.1038/ 366695a0
23. Shyjan AM, Bertagnolli M, Kenney CJ, Briskin MJ. Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the alpha 4 beta 7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. J Immunol 1996; 156:2851-7.
24. Briskin MJ, McEvoy LM, Butcher EC. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993; 363:461-4; PMID:8502297; http://dx.doi.org/ 10.1038/363461a0
25. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993; 143:1688-98.
26. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Patho 1997; 151:97-110; PMCID:PMC1857942
27. Pullen N, Molloy E, Carter D, Syntin P, Clemo F, Finco-Kent D, Reagan W, Zhao S, Kawabata T, Sreckovic S. Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody. Br J Pharmacol 2009; 157:281-93; PMID:19366349; http://dx.doi.org/10.1111/j.1476-5381.2009.00137.x
28. Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NH. I kappa B kinase complex alpha kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol 2004; 173:6161-8; PMID:15528353; http://dx.doi.org/10.4049/ jimmunol.173.10.6161
29. Xu B, Wagner N, Pham LN, Magno V, Shan Z, Butcher EC, Michie SA. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/ VCAM-1, and LFA-1 adhesion pathways. J Exp Med 2003; 197:1255-67; PMID:12756264; http://dx.doi. org/10.1084/jem.20010685
30. Nagatake T, Fukuyama S, Kim DY, Goda K, Igarashi O, Sato S, Nochi T, Sagara H, Yokota Y, Jetten AM. Id2-, RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity. J Exp Med 2009; 206:2351-64; PMID:19822644; http://dx.doi.org/10.1084/jem.20091436
31. Salmi M, Alanen K, Grenman S, Briskin M, Butcher EC, Jalkanen S. Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAd-CAM-1 in humans. Gastroenterology 2001; 121:853-64; PMID:11606499; http://dx.doi.org/10.1053/ gast.2001.27968
32. Mebius RE, Streeter PR, Michie S, Butcher EC, Weissman IL. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3-cells to colonize lymph nodes. Proc Natl Acad Sci USA 1996; 93:11019-24; PMID:8855301; http://dx.doi.org/10.1073/ pnas.93.20.11019
33. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006; 177:3369-79; PMID:16920978; http://dx.doi.org/10.4049/ jimmunol.177.5.3369
34. Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, Pan Y, Sheng M, Yago T, Silasi-Mansat R et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013; 502:105-9; PMID:23995678; http://dx.doi. org/10.1038/nature12501
35. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005; 106:444-6; PMID:15863780; http://dx.doi.org/ 10.1182/blood-2004-11-4353
36. Boscacci RT, Pfeiffer F, Gollmer K, Sevilla AI, Martin AM, Soriano SF, Natale D, Henrickson S, von Andrian UH, Fukui Y et al. Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood 2010; 116:915-25; PMID:20395417; http://dx.doi.org/10.1182/blood-2009-11-254334
37. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004; 4:360-70; PMID:15122201; http://dx.doi.org/10.1038/nri1354
38. Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, Yao K, Chu FF, Randolph GJ, Rudensky AY, Nussenzweig M. In vivo analysis of dendritic cell development and homeostasis. Science 2009; 324:392-7; PMID:19286519; http://dx.doi. org/10.1126/science.1171243
39. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med 2005; 202:687-96; PMID:16147979; http://dx.doi.org/10.1084/jem.20051035
40. Garrod KR, Wei SH, Parker I, Cahalan MD. Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets. Proc Natl Acad Sci USA 2007; 104:12081-6; PMID:17609379; http://dx.doi.org/ 10.1073/pnas.0702867104
41. Seth S, Oberdorfer L, Hyde R, Hoff K, Thies V, Worbs T, Schmitz S, F�rster R. CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J Immunol 2011; 186:3364-72; PMID:21296980; http://dx.doi.org/10.4049/ jimmunol.1002598
42. Dejana E. The transcellular railway: insights into leukocyte diapedesis. Nat Cell Biol 2006; 8:105-7; PMID:16450004; http://dx.doi.org/10.1038/ ncb0206-105
43. Subramanian H, Grailer JJ, Ohlrich KC, Rymaszewski AL, Loppnow JJ, Kodera M, Conway RM, Steeber DA. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. J Immunol 2012; 188:3223-36; PMID:22387549; http://dx.doi.org/10.4049/ jimmunol.1101032
44. Galkina E, Tanousis K, Preece G, Tolaini M, Kioussis D, Florey O, Haskard DO, Tedder TF, Ager A. Lselectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med 2003; 198:1323-35; PMID:14597735; http://dx.doi.org/ 10.1084/jem.20030485
45. Klinger A, Gebert A, Bieber K, Kalies K, Ager A, Bell EB, Westermann J. Cyclical expression of L-selectin (CD62L) by recirculating T cells. Int Immunol 2009; 21:443-55; PMID:19240088; http://dx.doi.org/ 10.1093/intimm/dxp012
46. Park EJ, Peixoto A, Imai Y, Goodarzi A, Cheng G, Carman CV, von Andrian UH, Shimaoka M. Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood 2010; 115:1572-81; PMID:20023213; http://dx.doi.org/10.1182/blood-2009-08-237917
47. Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol 2006; 8:156-62; PMID:16429129; http://dx.doi.org/10.1038/ ncb1355
48. Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 2008; 9:415-23; PMID:18327261; http://dx.doi.org/ 10.1038/ni1573
49. Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, Veeraveedu PT, Hata E, Sugiura Y, Kubo A et al. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J Immunol 2013; 190:2036-48; PMID:23365076; http://dx.doi.org/10.4049/jimmunol.1202025
50. Soriano SF, Hons M, Schumann K, Kumar V, Dennier TJ, Lyck R, Sixt M, Stein JV. In vivo analysis of uropod function during physiological T cell trafficking. J Immunol 2011; 187:2356-64; PMID:21795598; http://dx.doi.org/10.4049/ jimmunol.1100935
51. Mionnet C, Sanos SL, Mondor I, Jorquera A, Laugier JP, Germain RN, Baj�noff M. High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes. Blood 2011; 118:6115-22; PMID:21937697; http://dx.doi.org/ 10.1182/blood-2011-07-367409
52. Faveeuw C, Preece G, Ager A. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 2001; 98:688-95; PMID:11468168; http://dx.doi.org/10.1182/blood.V98.3.688
53. Lee M, Kiefel H, LaJevic MD, Macauley MS, Kawashima H,O'Hara E, Pan J,Paulson JC, Butcher EC. Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing. Nat Immunol 2014; 15 (10):982-995; PMID:4222088; http://dx.doi.org/ 10.1038/ni.2983
54. Hyun YM, Sumagin R, Sarangi PP, Lomakina E, Overstreet MG, Baker CM, Fowell DJ, Waugh RE, Sarelius IH, Kim M. Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels. J Exp Med 2012; 209:1349-62; PMID:22711877; http://dx.doi.org/10.1084/ jem.20111426
55. Hourihan H, Allen TD, Ager A. Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity. J Cell Sci 1993; 104:1049-59; http://dx.doi.org/ 10.1002/eji.1830130811
56. Yang BG, Tanaka T, Jang MH, Bai Z, Hayasaka H, Miyasaka M. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J Immunol 2007; 179:4376-82; http://dx. doi.org/10.4049/jimmunol.179.7.4376
57. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000; 192:1425-40; PMID:11085745; http://dx.doi.org/ 10.1084/jem.192.10.1425
58. Hendricks HR, Eestermans IL. Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration. Eur J Immunol 1983; 13:663-9; PMID:6884423; http://dx.doi. org/10.1002/eji.1830130811
59. Mebius RE, Streeter PR, Breve J, Duijvestijn AM, Kraal G. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol 1991; 115:85-95; PMID:1918141; http://dx.doi. org/10.1083/jcb.115.1.85
60. Drayson MT, Ford WL. Afferent lymph and lymph borne cells: their influence on lymph node function. Immunobiology 1984; 168:362-79; PMID:6530238; http://dx.doi.org/10.1016/S0171-2985(84)80123-0
61. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, Nibbs RJ et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10:101-8; PMID:19060902; http://dx.doi.org/ 10.1038/ni.1675
62. Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectindeficient mice. J Exp Med 1998; 187:197-204; PMID:9432977; http://dx.doi.org/10.1084/ jem.187.2.197
63. Guarda G, Hons M, Soriano SF, Huang AY, Polley R, Martin-Fontecha A, Stein JV, Germain RN, Lanzavecchia A, Sallusto F. L-selectin-negative CCR7-effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007; 8:743-52; PMID:17529983; http://dx.doi.org/ 10.1038/ni1469
64. Martin-Fontecha A, Baumjohann D, Guarda G, Reboldi A, Hons M, Lanzavecchia A, Sallusto F. CD40LC CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J Exp Med 2008; 205:2561-74; PMID:18838544; http:// dx.doi.org/10.1084/jem.20081212
65. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFNgamma for T(H)1 priming. Nat Immunol 2004; 5:1260-5; PMID:15531883; http://dx.doi.org/ 10.1038/ni1138
66. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, Narumi S, Morikawa S, Ezaki T, Lu B et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004; 16:915-28; PMID:15159375; http://dx.doi.org/ 10.1093/intimm/dxh093
67. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001; 194:1361-73; PMID:11696600; http:// dx.doi.org/10.1084/jem.194.9.1361
68. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 2001; 194:1375-84; PMID:11696601; http://dx.doi.org/10.1084/ jem.194.9.1375
69. Marchesi VT. The site of leucocyte emigration during inflammation. Quart J Exp Physiol 1961; 46:115-8; PMID:13766496; http://dx.doi.org/10.1113/ expphysiol.1961.sp001522
70. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/ science.1129139
71. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; PMID:16371631; http:// dx.doi.org/10.1056/NEJMoa051424
72. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26:4410-7; PMID:18802153; http://dx.doi.org/ 10.1200/JCO.2007.15.0284
73. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203-13; PMID:12529460; http://dx.doi.org/10.1056/ NEJMoa020177
74. Fridman WH, Galon J, Pages F, Tartour E, Sautes-Fridman C, Kroemer G. Prognostic and predictive impact of intra-and peritumoral immune infiltrates. Cancer Res 2011; 71:5601-5; PMID:21846822; http://dx.doi.org/10.1158/0008-5472.CAN-11-1316
75. Disis ML. Immune regulation of cancer. J Clin Oncol 2010; 28:4531-8; PMID:20516428; http://dx.doi. org/10.1200/JCO.2009.27.2146
76. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP. Human solid tumors contain high endothelial venules: association with T-and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678-87; PMID:21846823; http://dx.doi.org/ 10.1158/0008-5472.CAN-11-0431
77. Martinet L, Le Guellec S, Filleron T, Lamant L,Meyer N, Rochaix P, Garrido I, Girard JP. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. Oncoimmunology 2012; 1:829-39; PMID:23162750; http://dx.doi.org/10.4161/ onci.20492
78. Schrama D, thor Straten P, Fischer WH, McLellan AD, Brocker EB, Reisfeld RA, Becker JC Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14:111-21; PMID:11239444; http://dx.doi.org/10.1016/S1074-7613(01)00094-2
79. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004; 5:141-9; PMID:14704792; http://dx.doi.org/10.1038/ni1029
80. Hindley JP, Jones E, Smart K, Bridgeman H, Lauder SN, Ondondo B, Cutting S, Ladell K, Wynn KK, Withers D et al. T cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T cell depletion. Cancer Res 2012; 72:5473-82; PMID:22962270; http://dx.doi.org/ 10.1158/0008-5472.CAN-12-1912
81. Kobayashi M, Lee H, Schaffer L, Gilmartin TJ, Head SR, Takaishi S, Wang TC, Nakayama J, Fukuda M. A distinctive set of genes is upregulated during the inflammation-carcinoma sequence in mouse stomach infected by Helicobacter felis. J Histochem Cytochem 2007; 55:263-74; PMID:17101721; http://dx.doi. org/10.1369/jhc.6A7097.2006
82. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006; 7:344-53; PMID:16550197; http://dx.doi.org/10.1038/ni1330
83. Suzawa K, Kobayashi M, Sakai Y, Hoshino H, Watanabe M, Harada O, Ohtani H, Fukuda M, Nakayama J. Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis. Am J Gastroenterol 2007; 102:1499-509; PMID:17459027; http://dx. doi.org/10.1111/j.1572-0241.2007.01189.x
84. Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, Fukuda M. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci USA 2004; 101:17807-12; PMID:15591109; http:// dx.doi.org/10.1073/pnas.0407503101
85. Goc J, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology 2013; 2: e26836; PMID:24498556; http://dx.doi.org/ 10.4161/onci.26836
86. Cipponi A, Mercier M, Seremet T, Baurain JF, Theate I, van den Oord J, Stas M, Boon T, Coulie PG, van Baren N. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res 2012; 72:3997-4007; PMID:22850419; http://dx.doi.org/10.1158/0008-5472.CAN-12-1377
87. Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H, Hersh EM. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 2002; 169:1829-36; PMID:12165506; http://dx.doi.org/ 10.4049/jimmunol.169.4.1829
88. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999; 190:1417-26; PMID:10562317; http:// dx.doi.org/10.1084/jem.190.10.1417
89. Banner BF, Savas L, Baker S, Woda BA. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 64:213-20; PMID:8287117; http://dx.doi.org/10.1007/ BF02915115
90. Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E, Alifano M et al. Dendritic cells in tumorassociated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 2014; 74:705-15; PMID:24366885; http://dx. doi.org/10.1158/0008-5472.CAN-13-1342
91. Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15:6412-20; PMID:19825961; http://dx.doi.org/10.1158/1078-0432.CCR-09-1438
92. Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mul� JJ. Unique ectopic lymph nodelike structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol 2011; 179:37-45; PMID:21703392; http://dx.doi.org/10.1016/j.ajpath.2011.03.007
93. Nzula S, Going JJ, Stott DI. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 2003; 63:3275-80
94. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 2010; 328:749-52; http://dx.doi.org/ 10.1126/science.1185837
95. Bento DC, Jones E, Junaid S, Tull J, Williams GT, Godkin A, Ager A, Gallimore A. High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression, OncoImmunology, 2014; 4(3):e974374; http://dx. doi.org/10.4161/2162402X.2014.974374
96. Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, Laghi L, Allavena P, Mantovani A, Marchesi F. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res 2014; 20:2147-58; PMID:24523438; http://dx.doi.org/10.1158/1078-0432.CCR-13-2590
97. Rosen SD. Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol 1999; 155:1013-20; PMID:10514381; http:// dx.doi.org/10.1016/S0002-9440(10)65201-7
98. Avram G, Sanchez-Sendra B, Martin JM, Terradez L, Ramos D, Monteagudo C. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma. Histopathology 2013; 63:852-61; PMID:24102908; http://dx.doi. org/10.1111/his.12235
99. Turunen JP, Majuri ML, Seppo A, Tiisala S, Paavonen T, Miyasaka M, Lemstr�m K, Penttil� L, Renkonen O, Renkonen R. De novo expression of endothelial sialyl Lewisa and sialyl Lewis(x) during cardiac transplant rejection: Superior capacity of a tetravalent sialyl lewis(x) oligosaccharide in inhibiting Lselectin-dependent lymphocyte adhesion. J Exp Med 1995; 182:1133-42; PMID:7561686; http://dx.doi. org/10.1084/jem.182.4.1133
100. Baekkevold ES, Jahnsen FL, Johansen F-E, Bakke O, Gaudernack G, Brandtzaeg P, Haraldsen G. Culture characterization of differentiated high endothelial venule cells from human tonsils. Lab Invest 1999; 79:327-36; PMID:10092069
101. Tamatani T, Kuida K, Watanabe T, Koike S, Miyasaka M. Molecular mechanisms underlying lymphocyte recirculation: III. Characterization of the LECAM-1 (L-selectin)-dependent adhesion pathway in rats. J Immunol 1993; 150:1735-45.
102. Derry CJ, Faveeuw C, Mordsley KR, Ager A. Novel chondroitin sulfate-modified ligands for L-selectin on lymph node high endothelial venules. Eur J Immunol 1999; 29:419-30; PMID:10064057; http://dx.doi.org/10.1002/(SICI)1521-4141 (199902)29:02%3c419::AID-IMMU419%3e3.0. CO;2-A
103. Hendriks HR, Duijvestijn AM, Kraal G. Rapid decrease in lymphocyte adherence to high endothelial venules in lymph nodes deprived of afferent lymphatic vessels. Eur J Immunol 1987; 17:1691-5; PMID:3500859; http://dx.doi.org/10.1002/ eji.1830171203
104. Browning JL, Allaire N, Ngam-Ek A, Notidis E, Hunt J, Perrin S, Fava RA. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 2005; 23:539-50; PMID:16286021; http://dx.doi.org/ 10.1016/j.immuni.2005.10.002
105. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med 2006; 203:1903-13; PMID:16831898; http://dx.doi.org/10.1084/ jem.20052272
106. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, Gonzalez SF, Elpek KG, Chang SK, Knoblich K, Hemler ME et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 2012; 13:499-510; PMID:22466668; http://dx.doi. org/10.1038/ni.2262
107. Benezech C, White A, Mader E, Serre K, Parnell S, Pfeffer K, Ware CF, Anderson G, Caama�o JH. Ontogeny of stromal organizer cells during lymph node development. J Immunol 2010; 184:4521-30; PMID:20237296; http://dx.doi.org/10.4049/ jimmunol.0903113
108. Onder L, Danuser R, Scandella E, Firner S, Chai Q, Hehlgans T, Stein JV, Ludewig B. Endothelial cellspecific lymphotoxin-beta receptor signaling is critical for lymph node and high endothelial venule formation. J Exp Med 2013; 210:465-73; PMID:23420877; http://dx.doi. org/10.1084/jem.20121462
109. Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011; 479:542-6; PMID:22080953; http://dx.doi.org/10.1038/ nature10540
110. Wendland M, Willenzon S, Kocks J, Davalos-Misslitz AC, Hammerschmidt SI, Schumann K, Kremmer E, Sixt M, Hoffmeyer A, Pabst O et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 2011; 35:945-57; PMID:22195748; http://dx.doi.org/10.1016/j. immuni.2011.10.017
111. Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, Madri JA, Lu TT. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 2008; 181:3887-96; PMID:18768843; http://dx.doi.org/10.4049/ jimmunol.181.6.3887
112. Lindquist RL, Shakhar G, Dudziak D, Wardemann H, Eisenreich T, Dustin ML, Nussenzweig MC. Visualizing dendritic cell networks in vivo. Nat Immunol 2004; 5:1243-50; PMID:15543150; http://dx.doi. org/10.1038/ni1139
113. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N, Tripp CH, Douillard P, Leserman L, Kaiserlian D. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22:643-54; PMID:15894281; http://dx.doi.org/10.1016/j. immuni.2005.04.004
114. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008; 26:293-316; PMID:18045026; http://dx.doi.org/10.1146/ annurev.immunol.26.021607.090254
115. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010; 33:955-66; PMID:21130004; http://dx.doi.org/10.1016/j. immuni.2010.11.020
116. Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard JP. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin beta-producing dendritic cells in human breast cancer. J Immunol 2013; 191:2001-8; PMID:23825314; http://dx.doi.org/10.4049/ jimmunol.1300872
117. Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LX, Batra RK, Dubinett SM. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol 2000; 164:4558-63; PMID:10779757; http://dx.doi.org/ 10.4049/jimmunol.164.9.4558
118. Kirk CJ, Hartigan-O'Connor D, Mule JJ. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 2001; 61:8794-802.
119. Cuff CA, Sacca R, Ruddle NH. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol 1999; 162:5965-72.
120. Sun SC. The noncanonical NF-kappaB pathway. Immunol Rev 2012; 246:125-40; PMID: 22435551; http://dx.doi.org/10.1111/j.1600-065X. 2011.01088.x
121. Guo F, Weih D, Meier E, Weih F. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. Blood 2007; 110(7):2381-9; http://dx.doi.org/10.1182/ blood-2007-02-075143
122. Madge LA, May MJ. Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression. J Biol Chem; 285:38069-77; PMID:20923761; http://dx.doi.org/10.1074/jbc. M110.147207
123. Lovas A, Weidemann A, Albrecht D, Wiechert L, Weih D, Weih F. p100 Deficiency is insufficient for full activation of the alternative NF-kappaB pathway: TNF cooperates with p52-RelB in target gene transcription. PLoS One 2012; 7:e42741; PMID:22880094; http://dx.doi.org/10.1371/journal. pone.0042741
124. Pablos JL, Santiago B, Tsay D, Singer MS, Palao G, Galindo M, Rosen SD. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNFalpha in cultured endothelial cells. BMC Immunol 2005; 6:6; PMID:15752429; http://dx.doi.org/ 10.1186/1471-2172-6-6
125. Cuff CA, Schwartz J, Bergman CM, Russell KS, Bender JR, Ruddle NH. Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. J Immunol 1998; 161:6853-60; PMID:9862717
126. Sikorski EE, Hallmann R, Berg EL, Butcher EC. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factoralpha and IL-1. J Immunol 1993; 151:5239-50; PMID:7693807
127. Joyce JA and Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science 2015; 348:74-80; http://dx.doi.org/10.1126/science. aaa6204
128. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314:126-9; PMID:16946036; http://dx.doi.org/10.1126/ science.1129003
129. Fisher DT, Chen Q, Skitzki JJ, Muhitch JB, Zhou L, Appenheimer MM, Vardam TD, Weis EL, Passanese J, Wang WC et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J Clin Invest 2011; 121:3846-59; PMID:21926464; http://dx.doi.org/10.1172/ JCI44952
130. Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 2008; 14:28-36; PMID:18157142; http://dx.doi.org/10.1038/ nm1699
131. Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Boumater Steege JC et al. Antiangiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. FASEB J 2006; 20:621-30; PMID:16581970; http://dx.doi.org/ 10.1096/fj.05-4493com
132. Motz GT, Santoro SP, Wang LP, Garrabrant T,Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med 2014; 20(6):607-15; http:dx.doi.org/ 10.1038/nm.3541
133. Calcinotto A, Grioni M, Jachetti E, Curnis F, Mondino A, Parmiani G, Corti A, Bellone M. Targeting TNF-alpha to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy. J Immunol 2012; 188:2687-94; PMID:22323546; http://dx.doi.org/ 10.4049/jimmunol.1101877
134. Quezada SA, Peggs KS, Simpson TR, Shen Y, Littman DR, Allison JP. Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med 2008; 205:2125-38; PMID:18725522; http://dx.doi.org/10.1084/ jem.20080099
135. Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 2010; 70:6171-80; PMID:20631075; http://dx.doi.org/10.1158/0008-5472.CAN-10-0153
136. Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, Santosuosso M, Martin JD, Martin MR, Vianello F et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci USA 2012; 109:17561-6; PMID:23045683; http://dx.doi.org/ 10.1073/pnas.1215397109
137. Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, Rabie T, Kaden S, Gr�ne HJ, H�mmerling GJ et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008; 453:410-4; PMID:18418378; http://dx.doi.org/10.1038/nature06868
138. Berger M, Bergers G, Arnold B, Hammerling GJ, Ganss R. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005; 105:1094-101; PMID:15459006; http://dx.doi.org/ 10.1182/blood-2004-06-2315
139. Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res 2002; 62:1462-70; PMID:11888921
140. Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, Springer TA. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature 1996; 379:266-9; PMID:8538793; http://dx.doi.org/ 10.1038/379266a0
141. Cinamon G, Shinder V, Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2001; 2:515-22; PMID:11376338; http://dx.doi.org/ 10.1038/88710
142. Lanca T, Silva-Santos B. The split nature of tumorinfiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunology 2012; 1:717-25; PMID:22934263; http://dx.doi.org/ 10.4161/onci.20068